# Portrazza

NDC: 0002-7716
Generic name: necitumumab
Labeler / Manufacturer: Eli Lilly and Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: SOLUTION
Routes: INTRAVENOUS
Marketing started: 20151124
Marketing ended: 20260527
FDA application: BLA125547

## Active ingredients

- NECITUMUMAB: 16 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0002-7716"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0002-7716
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=89bcf553-669a-40b0-a9d7-67a5c1d2f591